Story perspectives

Rutgers Study: Ciprofloxacin Boosts E. Coli Resistance

6/11/2025

50 12

Summary

Story summary

A groundbreaking Rutgers Health study uncovers that ciprofloxacin, commonly prescribed for urinary tract infections, may unintentionally enhance E. coli's survival and resistance. By triggering an energy crisis, the drug forces bacteria to accelerate their metabolism and mutate rapidly. This alarming discovery highlights the urgent need to rethink antibiotic development to tackle the escalating threat of antibiotic resistance, responsible for 1.27 million deaths each year.

1 of 1

Story summary

A groundbreaking Rutgers Health study uncovers that ciprofloxacin, commonly prescribed for urinary tract infections, may unintentionally enhance E. coli's survival and resistance. By triggering an energy crisis, the drug forces bacteria to accelerate their metabolism and mutate rapidly. This alarming discovery highlights the urgent need to rethink antibiotic development to tackle the escalating threat of antibiotic resistance, responsible for 1.27 million deaths each year.